JANA ATKINS: Open Payments
NPI 1033173802 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,005 in 172 payments from 22 companies in 2025. Trend: 2023 $3,138 · 2024 $3,593 · 2025 $3,005
Food & beverage: $2,944Education: $61
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $560 |
| UCB, Inc. | 23 | $507 |
| ABBVIE INC. | 24 | $396 |
| Arcutis Biotherapeutics, Inc. | 25 | $189 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $175 |
| GENZYME CORPORATION | 11 | $150 |
| Amgen Inc. | 7 | $128 |
| REVANCE THERAPEUTICS, INC. | 3 | $117 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $98 |
Products named: TREMFYA, Bimzelx, DUPIXENT, RINVOQ, Zoryve, SKYRIZI, OTEZLA, DAXXIFY.
Industry payments across TX — which companies pay providers there.
